rosiglitazone has been researched along with methane in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chintharlapalli, S; Safe, S; Samudio, I; Smith, R; Zhang, W | 1 |
1 other study(ies) available for rosiglitazone and methane
Article | Year |
---|---|
1,1-Bis(3'-indolyl)-1-(p-substitutedphenyl)methanes induce peroxisome proliferator-activated receptor gamma-mediated growth inhibition, transactivation, and differentiation markers in colon cancer cells.
Topics: Apoptosis; Biomarkers, Tumor; Cell Cycle Proteins; Cell Differentiation; Cell Division; Cell Line, Tumor; Colonic Neoplasms; Humans; Indoles; Methane; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazolidinediones; Transcription Factors; Transcriptional Activation | 2004 |